119 related articles for article (PubMed ID: 6209058)
21. Immune complexes and cryoproteins in ascitic fluid of patients with alcoholic liver disease.
Quismorio FP; Kaufman RL; Halle P; Hoefs JC
Int Arch Allergy Appl Immunol; 1981; 64(2):190-4. PubMed ID: 6780467
[TBL] [Abstract][Full Text] [Related]
22. Ciliated ovarian adenocarcinoma cells in ascitic fluid cytology: report of a case with immunocytochemical features.
Kobayashi TK; Teraoka S; Tsujioka T; Yoshida Y
Diagn Cytopathol; 1988; 4(3):234-8. PubMed ID: 2474417
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of monoclonal antibody to a 60-kD glycoprotein in ovarian carcinoma.
Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ
Hybridoma; 1985; 4(2):153-62. PubMed ID: 3891588
[TBL] [Abstract][Full Text] [Related]
25. Tumor directed antibody and carcinoembryonic antigen in the glomeruli of a patient with gastric carcinoma.
Pascal RR; Slovin SF
Hum Pathol; 1980 Nov; 11(6):679-82. PubMed ID: 6450154
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
27. Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients.
Stallwood Y; Fisher KD; Gallimore PH; Mautner V
Gene Ther; 2000 Apr; 7(8):637-43. PubMed ID: 10800086
[TBL] [Abstract][Full Text] [Related]
28. Precipitation of 19S IgM rheumatoid factor-IgG circulating immune complexes in patients with juvenile arthritis by polyethylene glycol and separation by immobilized protein A.
Moore TL; Dorner RW; Sheridan PW; Zuckner J
Clin Exp Immunol; 1984 May; 56(2):247-52. PubMed ID: 6733970
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical study of one of ascitic fluid antigens in patients with ovarian cancer using normal and tumor tissues].
Sergeeva NS; Vasil'ev MIu; Sokolova NV; Avdeev GI
Eksp Onkol; 1988; 10(1):20-2. PubMed ID: 3131099
[TBL] [Abstract][Full Text] [Related]
30. [Circulating IgG-containing immune complexes in malignant growth].
Kostrzhevskaia EG
Eksp Onkol; 1986; 8(3):10-7. PubMed ID: 2424714
[TBL] [Abstract][Full Text] [Related]
31. Activity of antibodies recovered from immune complexes of ovarian cancer patients.
Lutz PM; Dawson JR
Cancer Immunol Immunother; 1984; 17(3):180-9. PubMed ID: 6383602
[TBL] [Abstract][Full Text] [Related]
32. [Case of Krukenberg's tumor originating in the stomach with a marked increase in the ascitic carcinoembryonic antigen (CEA) level in comparison with that of the blood].
Kohno H; Morimoto S; Onishi T; Tahara Y; Kumahara Y
Nihon Naika Gakkai Zasshi; 1983 Apr; 72(4):462-7. PubMed ID: 6310009
[No Abstract] [Full Text] [Related]
33. "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients.
Taylor DD; Homesley HD; Doellgast GJ
Am J Reprod Immunol (1980); 1983; 3(1):7-11. PubMed ID: 6859379
[TBL] [Abstract][Full Text] [Related]
34. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.
Sehested M; Ralfkjaer E; Rasmussen J
Acta Cytol; 1983; 27(2):124-7. PubMed ID: 6340401
[TBL] [Abstract][Full Text] [Related]
35. Identification of a human cancer-associated antigen defined with monoclonal antibody.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
[TBL] [Abstract][Full Text] [Related]
36. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms.
Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J
Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907
[TBL] [Abstract][Full Text] [Related]
37. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the physicochemical properties of carcinoembryonic antigen in extracts of tumour tissue, ascitic and cyst fluid from ovarian cancer.
Hill R; Daunter B; Magon H; Khoo SK; Mackay EV
Aust J Exp Biol Med Sci; 1981 Aug; 59(4):469-76. PubMed ID: 7295221
[TBL] [Abstract][Full Text] [Related]
39. [Distribution of one of the ascitic fluid antigens of ovarian cancer patients in malignant tumors of the stomach and intestines].
Sergeeva NS; Vasil'ev MIu; Kovalenko TI; Sokolova NV; Avdeev GI
Eksp Onkol; 1989; 11(2):35-7. PubMed ID: 2661204
[TBL] [Abstract][Full Text] [Related]
40. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
